Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gerald Cox Rare Care Consulting is a private healthcare consulting company focused on advising biotechnology companies developing investigational therapies for rare genetic diseases. The firm was founded by Gerald F. Cox, MD, PhD, a clinical geneticist and former biotechnology executive with experience in rare disease drug development at Genzyme, Sanofi Genzyme, and Editas Medicine. Its work appears to center on clinical development strategy across multiple stages rather than operating an internal drug pipeline. Publicly available descriptions indicate expertise spanning enzyme replacement therapies, genome editing, and other therapies for rare inherited disorders. The company is best characterized as a specialized rare disease clinical development consultancy rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gerald Cox Rare Care Consulting.